Richard Whitley

Richard Whitley

Director/Board Member bij VIRIOS THERAPEUTICS, INC.

Vermogen: 335 $ op 31-03-2024

78 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Richard J.
Whitley
is the founder of Treovir LLC (2019) and Alabama Drug Discovery Alliance.
He is currently a Director at Primus Pharmaceuticals, Inc., an Independent Director at Virios Therapeutics, Inc. (2020-present), a Director at FermaVir Pharmaceuticals LLC, Co-Director-Pediatric Infectious Diseases at Washington University School of Medicine, a Member of the Association of American Physicians, a Member of the American Society of Clinical Investigation, a Professor at The University of Alabama at Birmingham, and a Member-Supervisory Board at Leyden Laboratories B.V.
Dr. Whitley's former positions include Chairman-Scientific Councilors at Centers for Disease Control & Prevention (2000-2012), Chairman-HIV Vaccine Data Safety at National Institute of Allergy & Infectious Diseases, Independent Director at Gilead Sciences, Inc. (2008-2021), Director at Gilead Connecticut, Inc., President of Infectious Diseases Society of America, and President of The International Society for Antiviral Research.
Dr. Whitley's education includes an undergraduate degree and a doctorate from Duke University and a doctorate from George Washington University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
26-02-2024 700 ( 0.00% ) 335 $ 31-03-2024

Actieve functies van Richard Whitley

BedrijvenFunctieBegin
VIRIOS THERAPEUTICS, INC. Director/Board Member 21-12-2020
Director/Board Member 16-08-2005
Director/Board Member -
Corporate Officer/Principal -
American Society of Clinical Investigation Corporate Officer/Principal -
Founder -
Washington University School of Medicine Corporate Officer/Principal -
The University of Alabama at Birmingham Corporate Officer/Principal -
Director/Board Member -
Alle actieve functies van Richard Whitley

Eerdere bekende functies van Richard Whitley

BedrijvenFunctieEinde
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░ ░░░░░░░ -
░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░ -
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Ervaring van Richard Whitley in detail bekijken

Opleiding van Richard Whitley

Duke University Doctorate Degree
George Washington University Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Richard Whitley in detail bekijken

Connecties

100 +

Eerstegraads connecties

18

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
GILEAD SCIENCES, INC.

Health Technology

VIRIOS THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit12

Retail Trade

Health Technology

Government

Health Technology

Commercial Services

American Society of Clinical Investigation

National Institute of Allergy & Infectious Diseases

Government

Commercial Services

Commercial Services

Health Technology

Commercial Services

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Richard Whitley